Fundación CEMAIC ( Site 0410)
Córdoba X5008HHW
0 studies enrolling now · 1 studies all time
What they study most
Breast Neoplasms
Studies at this site
Study of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy for HR+/HER2- Locally Recurrent Inoperable or Metastatic Breast Cancer (MK-3475-B49/KEYNOTE-B49)
— Running, not enrolling